G. Elizondo et P. Ostroskywegman, EFFECTS OF METRONIDAZOLE AND ITS METABOLITES ON HISTAMINE IMMUNOSUPPRESSION ACTIVITY, Life sciences, 59(4), 1996, pp. 285-297
Citations number
39
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
We have previously reported that metronidazole treatment increases hum
an lymphocyte proliferation showing individual differences. This drug
and its metabolites are imidazole compounds like histamine and cimetid
ine. The first is an endogenous amine that inhibits T-helper lymphocyt
e proliferation, and the second is a histamine antagonist. We presentl
y report the in vitro effects of histamine, cimetidine, imidazole, met
ronidazole and its two principal metabolites (the acetic acid and hydr
oxy forms), on the mitogenic response to phytohemagglutinin (PHA) stim
ulation of human peripheral blood lymphocytes. Histamine decreased lym
phocyte proliferation while (in order of potency) cimetidine, the hydr
oxy metabolite of metronidazole, imidazole and metronidazole, increase
d the mitogenic response to PHA in a dose-response fashion. The acetic
acid metabolite lacked immunomodulatory effects. Competitive studies
showed that cimetidine, metronidazole, and the hydroxy metabolite bloc
ked the inhibitory effect of histamine on lymphocyte proliferation in
a dose-related manner. This blockage was non-competitive, suggesting t
hat the target of the imidazole compounds was not the active site of t
he H-2 receptor.